Donald J Trump (R) Sells Intuitive Surgical, Inc. Shares
Donald J Trump sold Intuitive Surgical shares valued between $50,001 and $100,000.
Financial Disclosure Report
United States Congress • Office of Public Records • Washington, DC
Filer Information
- Name:
- Donald J Trump (R)
- Status:
- Member
- Party:
- republican
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jul 1, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Intuitive Surgical, Inc. ($ISRG) | Sell | May 22, 2026 | $50,001 - $100,000 |
Key Points
- Donald J Trump sold Intuitive Surgical shares valued between $50,001 and $100,000, reported on July 1, 2026.
- Intuitive Surgical traded near $397.68 on Wednesday with a market cap of $140.8 billion and a P/E ratio of 48.3.
- Insiders and analysts maintain interest in Intuitive Surgical, with recent insider sales and analyst price targets averaging $565.08.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On July 1, 2026, it was reported that Donald J Trump, a member of the Republican party, sold shares of Intuitive Surgical, Inc. (NasdaqGS: ISRG). The transaction, which occurred on May 22, 2026, involved a sale valued between $50,001 and $100,000.
Donald J Trump vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in Intuitive Surgical
Several institutional investors have also been active in Intuitive Surgical. BlackRock, Inc. reduced its holdings by 440,248 shares, leaving it with 30,075,905 shares worth approximately $13.86 billion. Vanguard Capital Management LLC opened a new position with 23,079,490 shares valued at over $10.63 billion. Meanwhile, State Street Corp added 145,382 shares, bringing its total to 15,846,973 shares valued around $7.31 billion. Price T Rowe Associates Inc /MD/ trimmed its stake by 34,756 shares, holding 12,520,007 shares worth about $5.77 billion. Geode Capital Management, LLC increased its position by 241,160 shares, ending with 8,466,851 shares valued at $3.89 billion.
Intuitive Surgical, Inc. Stock Up 6.7%
Shares of Intuitive Surgical, Inc. (NasdaqGS: ISRG) traded near $397.68 on Wednesday. The company has a market capitalization of approximately $140.8 billion and a P/E ratio of 48.3, with a forward P/E of 33.7. It has a beta of 1.453, indicating a higher volatility compared to the market average. The stock's 52-week range is between $396.68 and $603.88, with a 50-day moving average of $432.93 and a 200-day moving average of $489.03. Intuitive Surgical maintains a strong liquidity position with a current ratio of 4.61 and a quick ratio of 3.259.
$ISRG stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Intuitive Surgical reported revenue of $10.58 billion with a growth rate of 23%. The company's net margin stands at 28.2%, and its return on equity is 17.2%. The next earnings report is anticipated on July 16, 2026.
Insider Buying and Selling at Intuitive Surgical, Inc.
Recent insider activity at Intuitive Surgical includes several transactions. Mark Brosius, EVP & Chief Manufacturing and Supply Chain, sold 25 shares at $414.13 on June 12, 2026, and 23 shares at $412.16 on June 11, 2026, both under planned sales. Gary Loeb, EVP & Chief Legal and Compliance, sold 400 shares at $424.14 on June 10, 2026, also as a planned sale. CEO David Rosa made multiple transactions on June 10, 2026, selling 1,358 shares at an undisclosed price and 674 shares at $426.61, with some transactions not planned.
Analysts Set New Price Targets
Analysts have set new price targets for Intuitive Surgical. On May 18, 2026, B of A Securities maintained a 'buy' rating with a $520 price target. Barclays, on April 23, 2026, also maintained a 'buy' rating with a target of $651. Other firms like Leerink Partners and Baird maintained 'buy' ratings with targets of $573 and $610, respectively. The consensus among 29 analysts is a 'buy' rating, with an average target price of $565.08.
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a healthcare company based in Sunnyvale, California. It specializes in the development and manufacturing of medical instruments and supplies, focusing on minimally invasive care. The company is known for its da Vinci Surgical System, which allows for advanced surgical procedures. Intuitive Surgical also offers the Ion endoluminal system for diagnostic procedures, along with a range of other medical tools and services. Led by CEO David J. Rosa, the company employs over 17,000 people worldwide.
Bottom Line
Donald J Trump's sale of Intuitive Surgical shares highlights the ongoing interest in the company. Shares are trading within their 52-week range, and the company maintains a strong financial position. Insider transactions and analyst ratings suggest continued attention from both the market and investors. As always, it's important to remember that such transactions are reported after the fact and may not reflect current positions.
Get Intuitive Surgical, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ISRG, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.